Efficacy and safety of yttrium-aluminium garnet (YAG) laser vitreolysis for vitreous floaters
- PMID: 30200800
- PMCID: PMC6259370
- DOI: 10.1177/0300060518794245
Efficacy and safety of yttrium-aluminium garnet (YAG) laser vitreolysis for vitreous floaters
Abstract
Objective: To examine the efficacy and safety of yttrium-aluminium garnet (YAG) laser vitreolysis for the treatment of vitreous floaters.
Methods: Consecutive adult patients with symptomatic vitreous floaters who attended Chongqing General Hospital from April to December 2016 were included in this prospective study. Patients had >3 mm between the vitreous opacity and retina/lens and acceptable quality peri-papillary Optical Coherence Tomography (OCT) images (i.e., signal strength ≥5). Those with history of glaucoma, severe cataracts, vitreous haemorrhages, retinal holes and/or macular disease were excluded from the study. Best corrected visual acuity (BCVA) and non-contact intraocular pressure (IOP) were measured before and for up to 6 months post-YAG laser vitreolysis. Anterior segment photography and peripapillary retinal nerve fibre layer (RNFL) measured by OCT were taken before and 6 months post-procedure. Questionnaires on patient satisfaction were completed 6 months post-procedure.
Results: No statistically significant differences in BCVA and IOP were observed before or after treatment. Anterior segment photography showed that vitreous opacities partially or completely disappeared after YAG laser treatment. The thickness of RNFL in four directions (upper, below, nasal and temporal) was not statistically significant different before or 6 months after the procedure. 75% patients reported significant improvement and 25% reported moderate improvement.
Conclusion: The results of this study conducted in a cohort of 30 Chinese patients showed that YAG laser vitreolysis was a well-tolerated and effective treatment for vitreous floaters. Randomised, controlled trials involving large numbers of participants monitored over an extended follow up period are required to confirm these results.
Keywords: Yttrium-aluminium Garnet laser vitreolysis; anterior segment photography; optical coherence tomography; peripapillary retinal nerve fibre layer; vitreous floaters.
Figures

Similar articles
-
Assessment of Vitreous Structure and Visual Function after Neodymium:Yttrium-Aluminum-Garnet Laser Vitreolysis.Ophthalmology. 2019 Nov;126(11):1517-1526. doi: 10.1016/j.ophtha.2019.06.021. Epub 2019 Jun 22. Ophthalmology. 2019. PMID: 31471088 Free PMC article.
-
YAG Laser Vitreolysis vs Sham YAG Vitreolysis for Symptomatic Vitreous Floaters: A Randomized Clinical Trial.JAMA Ophthalmol. 2017 Sep 1;135(9):918-923. doi: 10.1001/jamaophthalmol.2017.2388. JAMA Ophthalmol. 2017. PMID: 28727887 Free PMC article. Clinical Trial.
-
Cataracts induced by neodymium-yttrium-aluminium-garnet laser lysis of vitreous floaters.Br J Ophthalmol. 2017 Jun;101(6):709-711. doi: 10.1136/bjophthalmol-2016-309005. Epub 2016 Aug 29. Br J Ophthalmol. 2017. PMID: 27574177
-
Laser vitreolysis for symptomatic floaters is not yet ready for widespread adoption.Surv Ophthalmol. 2020 Sep-Oct;65(5):589-591. doi: 10.1016/j.survophthal.2020.02.007. Epub 2020 Mar 3. Surv Ophthalmol. 2020. PMID: 32135173 Review.
-
Safety and Efficacy of YAG Laser Vitreolysis for the Treatment of Vitreous Floaters: An Overview.Adv Ther. 2020 Apr;37(4):1319-1327. doi: 10.1007/s12325-020-01261-w. Epub 2020 Feb 21. Adv Ther. 2020. PMID: 32086749 Free PMC article. Review.
Cited by
-
Efficacy Evaluation of the VFQ-25 Scale in Patients with Different Degrees of Vitreous Opacity After Nd : YAG Laser Ablation.Evid Based Complement Alternat Med. 2022 Sep 28;2022:5075447. doi: 10.1155/2022/5075447. eCollection 2022. Evid Based Complement Alternat Med. 2022. Retraction in: Evid Based Complement Alternat Med. 2023 Aug 16;2023:9870497. doi: 10.1155/2023/9870497. PMID: 36212958 Free PMC article. Retracted.
-
Efficacy and safety of Nd: YAG laser vitreolysis in patients with physiological vitreous floaters.BMC Ophthalmol. 2025 Aug 27;25(1):487. doi: 10.1186/s12886-025-04311-5. BMC Ophthalmol. 2025. PMID: 40866907 Free PMC article.
-
The effectiveness of laser vitreolysis for vitreous floaters in posterior vitreous detachment.Indian J Ophthalmol. 2022 Aug;70(8):3026-3032. doi: 10.4103/ijo.IJO_3198_21. Indian J Ophthalmol. 2022. PMID: 35918966 Free PMC article.
-
Advanced Optical Analysis of Divergence Between the Foci of the Neodymium-Doped Yttrium Aluminum Garnet (Nd:YAG) and Aiming Beam Lasers.Ophthalmol Sci. 2024 Mar 16;4(5):100512. doi: 10.1016/j.xops.2024.100512. eCollection 2024 Sep-Oct. Ophthalmol Sci. 2024. PMID: 38881607 Free PMC article.
-
Practical applications of vitreous imaging for the treatment of vitreous opacities with YAG vitreolysis.Int Ophthalmol. 2023 Oct;43(10):3587-3594. doi: 10.1007/s10792-023-02765-4. Epub 2023 Jul 4. Int Ophthalmol. 2023. PMID: 37402010
References
-
- Sendrowski DP, Bronstein MA. Current treatment for vitreous floaters. Optometry 2010; 81: 157–161. - PubMed
-
- Lumi X, Hawlina M, Glavač D, et al. Ageing of the vitreous: From acute onset floaters and flashes to retinal detachment. Ageing Res Rev 2015, 21: 71–77. - PubMed
-
- Shaimova VA, Shaimov TB, Shaimov RB, et al. Evaluation of YAG-laser vitreolysis effectiveness based on quantitative characterization of vitreous floaters. Vestn Oftalmol 2018, 134: 56–62. [Article in Russian] - PubMed
-
- Nishiguchi K. Functional regulation of heparin-binding proteins and maintenance of vitreal transparency by intravitreal glucosaminoglycan. Nihon Ganka Gakkai Zasshi 2012; 116: 1052–1061. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous